Purchase acomplia

One of the hot new diet pills in the news is Rimonabant Diet Pills. It was created to help people quit smoking and lose fat by blocking circuitry in the brain that gives the body cravings.

The diet pills, rimonabant accomplia is an appetite suppressant, but works by an entirely new approach by blocking the same primeval circuitry in the brain that gives pot-smokers the munchies. The French firm Sanofi-Synthelabo plans to seek U.S. approval to sell it under the brand “Accomplia” after more studies are finished next year. A study found that the pills helped people drop 20 pounds in a year, while the other concluded it increased smokers’ success at quitting, at least in the short-term. The drug will be marketed both for dieting and smoking cessation.

After a year, those who got the higher of two doses of Rimonabant had lost an average of 20 pounds and trimmed three inches from their waists. Nearly half of them took off 10 percent of their body weight. By comparison, those on placebos lost just five pounds. Those receiving accomplia improved in other ways, as well: their levels of good cholesterol rose 23 percent, while their triglycerides fell 15 percent.

In a recent study, 1,036 overweight or obese patients with blood lipid disorders were randomly placed in one of three groups (placebo vs. 5 mg or 20 mg per day of Rimonabant-Acomplia). After one year of treatment, patients receiving 20 mg per day of Rimonabant-Acomplia lost an average of 20 pounds, compared to only 5 pounds for patients on placebo. Further comparisons between the placebo and 20 mg per day Rimonabant-Acomplia group showed that the latter patients enjoyed significant improvements in waist circumference and HDL-C and triglyceride levels, all important factors in maintaining heart health. The drug was said to be well tolerated, with only mild and transient side effects like dizziness and gastrointestinal distress. The drug is currently only approved for sale in Europe, with a date for U.S. availability still uncertain